Glucokinase regulatory protein genetic variant interacts with Omega-3 PUFA to influence insulin resistance and inflammation in metabolic syndrome

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Perez Martinez, Pablo ^a   Delgado Lista, Javier ^a   Garcia Rios, Antonio ^a   Mc Monagle, Jolene ^b   Gulseth, Hanne L ^c   Ordovas, Jose M ^d,e   Shaw, Danielle I ^f   Karlström, Brita ^g   Kiec Wilk, Beata ^h   Blaak, Ellen E ⁱ   Helal, Olfa ^j   Malczewska Malec, Małgorzata ^h   Defoort, Catherine ^j   Risérus, Ulf ^g   Saris, Wim H M ⁱ   Lovegrove, Julie A ^f   Drevon, Christian A ^k   Roche, Helen M ^b   Lopez Miranda, Jose ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d TUFTS UNIVERSITY   (United States)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^f UNIVERSITY OF READING   (United Kingdom)

^g UPPSALA UNIVERSITY   (Sweden)

^h JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

ⁱ MAASTRICHT UNIVERSITY   (Netherlands)

^j INSERM   (France)

^k UNIVERSITY OF OSLO   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; C REACTIVE PROTEIN; FATTY ACID; GLUCOKINASE REGULATORY PROTEIN; GLUCOSE; INSULIN; OMEGA 3 FATTY ACID; REGULATOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; MONOUNSATURATED FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GENE DIET INTERACTION; GENE INTERACTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE HOMEOSTASIS; HETEROZYGOTE; HOMEOSTASIS; HOMOZYGOTE; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PROTEIN BINDING;

ADULT; AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARRIER PROTEINS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; GENETIC LOCI; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN BINDING;

EID: 79958169345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020555     Document Type: Article

References (33)

1. Reaven G, (2002) Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106: 286-288.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N, (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843.
3. Lopez-Miranda J, Perez-Martinez P, Marin C, Fuentes F, Delgado J, et al. (2007) Dietary fat, genes and insulin sensitivity. J Mol Med 85: 213-226.
4. Noel SE, Newby PK, Ordovas JM, Tucker KL, (2010) Adherence to an (n-3) fatty acid/fish intake pattern is inversely associated with metabolic syndrome among Puerto Rican adults in the Greater Boston area. J Nutr 140: 1846-1854.
5. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 1113-1118.
6. Jenkins DJ, Josse AR, Dorian P, Burr ML, LaBelle Trangmar R, et al. (2008) Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias. J Am Coll Nutr 27: 367-378.
7. Djousse L, Gaziano JM, Buring JE, Lee IM, (2011) Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr 93: 143-150.
8. O'Doherty RM, Lehman DL, Telemaque-Potts S, Newgard CB, (1999) Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48: 2022-2027.
9. Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, et al. (2008) Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57: 3112-3121.
10. Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, et al. (2009) The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 18: 4081-4088.
11. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
12. Vaxillaire M, Cavalcanti-Proenca C, Dechaume A, Tichet J, Marre M, et al. (2008) The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 57: 2253-2257.
13. Perez-Martinez P, Corella D, Shen J, Arnett DK, Yiannakouris N, et al. (2009) Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states. Am J Clin Nutr 89: 391-399.
14. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
15. Chasman DI, Pare G, Zee RY, Parker AN, Cook NR, et al. (2008) Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet 1: 21-30.
16. Qi Q, Wu Y, Li H, Loos RJ, Hu FB, et al. (2009) Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia 52: 834-843.
17. van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, et al. (2010) Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet 19: 387-395.
18. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, et al. (2008) Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 82: 1185-1192.
19. Kaushik M, Mozaffarian D, Spiegelman D, Manson JE, Willett WC, et al. (2009) Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr 90: 613-620.
20. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH, (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78: 91-98.
21. Laaksonen DE, Lakka TA, Lakka HM, Nyyssonen K, Rissanen T, et al. (2002) Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 19: 456-464.
22. Ferguson JF, Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, et al. (2010) Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr 91: 794-801.
23. Perez-Martinez P, Lopez-Miranda J, Cruz-Teno C, Delgado-Lista J, Jimenez-Gomez Y, et al. (2008) Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J Nutr 138: 1609-1614.
24. Roth U, Jungermann K, Kietzmann T, (2002) Activation of glucokinase gene expression by hepatic nuclear factor 4alpha in primary hepatocytes. Biochem J 365: 223-228.
25. Jump DB, Clarke SD, Thelen A, Liimatta M, (1994) Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res 35: 1076-1084.
26. Perez-Martinez P, Moreno-Conde M, Cruz-Teno C, Ruano J, Fuentes F, et al. (2010) Dietary fat differentially influences regulatory endothelial function during the postprandial state in patients with metabolic syndrome: from the LIPGENE study. Atherosclerosis 209: 533-538.
27. Ferguson JF, Phillips CM, McMonagle J, Perez-Martinez P, Shaw DI, et al. (2010) NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids. Atherosclerosis 211: 539-544.
28. (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
29. Shaw DI, Tierney AC, McCarthy S, Upritchard J, Vermunt S, et al. (2009) LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br J Nutr 101: 750-759.
30. Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, et al. (2010) Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond).
31. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25: 1751-1762.
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
33. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, et al. (2003) Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 89: 483-489.